The aim of the current study was to form prototype theranostic tracer-HA-SA conjugate-based NPs, characterize their self-assembly, drug loading and selective cytotoxicity to human ovarian cancer cells overexpressing CD44. The gene discussed is CD44; the disease is ovarian carcinoma.